These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 4130247

  • 21. Sulphate conjugation and L-dopa treatment of Parkinsonian patients.
    Rutledge CO, Hoehn MM.
    Nature; 1973 Aug 17; 244(5416):447-50. PubMed ID: 4582501
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Long-term treatment of Parkinson's disease with levodopa.
    Campbell JB.
    Neurology; 1970 Dec 17; 20(12):18-22. PubMed ID: 5531291
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Slowly absorbed L-dopa preparation in the treatment of parkinsonism.
    Laitinen LV.
    Acta Neurol Scand; 1973 Dec 17; 49(3):331-8. PubMed ID: 4747020
    [No Abstract] [Full Text] [Related]

  • 27. Levodopa in Parkinsonism.
    Weiss JL, Chase TN.
    Drugs; 1971 Dec 17; 2(4):257-61. PubMed ID: 4948349
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Urinary excretion of dopamine and homovanillic acid during L-dopa treatment of Parkinson's disease.
    Streifler M, Vardi Y, Kesten M, Oberman Z, Herzberg M.
    Isr J Med Sci; 1972 May 17; 81(5):597-601. PubMed ID: 5042950
    [No Abstract] [Full Text] [Related]

  • 31. Catecholamine metabolism during oral administration of levodopa.
    Hinterberger H, Andrews CJ.
    Arch Neurol; 1972 Mar 17; 26(3):245-52. PubMed ID: 5061285
    [No Abstract] [Full Text] [Related]

  • 32. Improvement in mono-manual dexterity in parkinsonism when supplementing levodopa with an extracerebral decarboxylase inhibitor, RO 4-4602.
    Knutsson E, Mårtensson A.
    Scand J Rehabil Med; 1974 Mar 17; 6(2):89-93. PubMed ID: 4837060
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Modification of Parkinsonism--chronic treatment with L-dopa.
    Cotzias GC, Papavasiliou PS, Gellene R.
    N Engl J Med; 1969 Feb 13; 280(7):337-45. PubMed ID: 4178641
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Levodopa and L-tryptophan therapy in Parkinsonism.
    Coppen A, Metcalfe M, Carroll JD, Morris JG.
    Lancet; 1972 Mar 25; 1(7752):654-8. PubMed ID: 4125162
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.